SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
---|---|---|---|---|---|
SampleID | NumReplicates | Organism | TissueType | CellType | MHCAllele |
SYSMHC00033_20160513_TIL1 | 2 | Human | HLA-A02:01,HLA-B18:01,HLA-B38:01,HLA-C05:01 | ||
SYSMHC00033_20160513_TIL2 | 2 | Human | no allele | ||
SYSMHC00033_20160513_TIL3 | 2 | Human | HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 | ||
SYSMHC00033_20160513_TIL4 | 2 | Human | no allele | ||
SYSMHC00033_20160517_DC | 5 | Human | no allele | ||
SYSMHC00033_20160517_GD149 | 5 | Human | HLA-A01:01,HLA-A24:02,HLA-B38:01,HLA-B44:03,HLA-C06:02,HLA-C12:03 | ||
SYSMHC00033_Apher-1 | 2 | Human | HLA-A03:01,HLA-A29:02,HLA-B44:02,HLA-B44:03,HLA-C12:03,HLA-C16:01 | ||
SYSMHC00033_Apher-6 | 2 | Human | HLA-A02:01,HLA-A03:01,HLA-B07:02,HLA-C07:02 | ||
SYSMHC00033_CM647_MG | 2 | Human | HLA-A01:01,HLA-A24:02,HLA-B13:02,HLA-B39:06,HLA-C06:02,HLA-C12:03 | ||
SYSMHC00033_CM647_NG | 2 | Human | HLA-A01:01,HLA-A24:02,HLA-B13:02,HLA-B39:06,HLA-C06:02,HLA-C12:03 | ||
SYSMHC00033_HLApI_TIL3 | 3 | Human | HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 | ||
SYSMHC00033_HLApI_pooledTIL3 | 3 | Human | HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 | ||
SYSMHC00033_MD155 | 3 | Human | HLA-A02:01,HLA-A24:02,HLA-B15:01,HLA-B18:01,HLA-C03:03,HLA-C07:01 | ||
SYSMHC00033_PD42 | 2 | Human | HLA-A02:06,HLA-A24:02,HLA-B07:02,HLA-B55:01,HLA-C01:02,HLA-C07:02 | ||
SYSMHC00033_RA957_MG | 2 | Human | HLA-A02:20,HLA-A68:01,HLA-B35:03,HLA-B39:01,HLA-C04:01,HLA-C07:02 | ||
SYSMHC00033_RA957_NG | 2 | Human | HLA-A02:20,HLA-A68:01,HLA-B35:03,HLA-B39:01,HLA-C04:01,HLA-C07:02 |
ID | SampleID | RawFileName | Organism | Process | Tissue Type | Cell Type | Culture Conditions | Disease State | Comments | MHCClass | MHCAllele | PubMed ID | Peptide | Isolation Method | Antibody | Mass Spectrometer | LC System | iRT Peptides | Acquisition Mode | Fragmentation Method | Gradient | Gradient Length | Flow Rate | Replicate Number |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | SampleID | RawFileName | Organism | Process | Tissue_Type | Cell_Type | Culture_Conditions | Disease_State | Comments | MHCClass | MHCAllele | PubMed_ID | Peptide | Isolation_Method | Antibody | Mass_Spectrometer | LC_System | iRT_Peptides | Acquisition_Mode | Fragmentation_Method | Gradient | Gradient_Length | Flow_Rate | Replicate_Number |
SYSMHC00033 | SYSMHC00033_20160513_TIL3 | 20160513_TIL3_R1.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 | 28832583 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | Dionex Ultimate RSLC3004 nanoLC | no | DDA | HCD | 1 | ||||
SYSMHC00033 | SYSMHC00033_20160513_TIL3 | 20160513_TIL3_R2.raw | Human | In vitro | Blood | Lymphoblast cell | suspension | EBV transformed | class I | HLA-A01:01,HLA-A23:01,HLA-B07:02,HLA-B15:01,HLA-C12:03,HLA-C14:02 | 28832583 | native | Immunoaffinity | W6/32 | Orbitrap Fusion Lumos | Dionex Ultimate RSLC3005 nanoLC | no | DDA | HCD | 2 |